Breakthrough: Chinese Drug Ivonescimab Outperforms Top Treatment
A new cancer drug, Ivonescimab, developed by a Chinese firm, outperformed Keytruda in late-stage trials, igniting global excitement in biotech innovation.
Stay informed, stay connected—news for amigos everywhere.
A new cancer drug, Ivonescimab, developed by a Chinese firm, outperformed Keytruda in late-stage trials, igniting global excitement in biotech innovation.
Scientists uncover a key mechanism behind heavy-ion cancer therapy, paving the way for more effective radiotherapy.
China and the IAEA have teamed up to train African radiation therapy physicists in Chengdu, boosting the fight against cancer across the continent. 🌍🎗️